InvestorsHub Logo
Followers 2
Posts 83
Boards Moderated 0
Alias Born 07/18/2020

Re: Blue Man post# 110987

Wednesday, 08/26/2020 12:28:17 AM

Wednesday, August 26, 2020 12:28:17 AM

Post# of 233066

In my thinking, even though a P3 trial to meet Primary is important to the success, the secondaries, if statistically significant is NO reason to shelve this treatment for Covid.



I think they will have to abandon that trial and start a new one with a different primary endpoint and/or more participants. From what I read you can also change the endpoint some time before unblinding but they are not doing that, I don’t know why.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News